Skip to main content
Addgene

MP28445 – pFUSE2ss-aRD114_CLIg-mIgK
(Plasmid #110556)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 110556 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pFUSEss
  • Backbone manufacturer
    Invivogen
  • Backbone size w/o insert (bp) 3456
  • Total vector size (bp) 4162
  • Vector type
    Mammalian Expression, Bacterial Expression
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Blasticidin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    anit-RD114 light chain
  • Alt name
    aRD114_CLIg-mIgK
  • Species
    RD114 retrovirus
  • GenBank ID
    NCBI:txid11834
  • Promoter EF-1 alpha core promoter
  • Tag / Fusion Protein
    • mKappa (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site EcoRI (not destroyed)
  • 3′ cloning site NheI (not destroyed)
  • 5′ sequencing primer n/a
  • 3′ sequencing primer n/a
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    MP28445 – pFUSE2ss-aRD114_CLIg-mIgK was a gift from Martin Pule (Addgene plasmid # 110556 ; http://n2t.net/addgene:110556 ; RRID:Addgene_110556)
  • For your References section:

    Generation of a neutralizing antibody against RD114-pseudotyped viral vectors. Mekkaoui L, Ferrari M, Mattiuzzo G, Ma B, Nannini F, Onuoha S, Kotsopoulou E, Takeuchi Y, Pule M. J Gen Virol. 2019 Nov 8. doi: 10.1099/jgv.0.001309. 10.1099/jgv.0.001309 PubMed 31702531